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Abstract
Eukaryotic mRNA decay is a highly regulated process allowing cells to rapidly modulate protein production in response to
internal and environmental cues. Mature translatable eukaryotic mRNAs are protected from fast and uncontrolled
degradation in the cytoplasm by two cis-acting stability determinants: a methylguanosine (m7G) cap and a poly(A) tail at
their 59 and 39 extremities, respectively. The hydrolysis of the m7G cap structure, known as decapping, is performed by the
complex composed of the Dcp2 catalytic subunit and its partner Dcp1. The Dcp1-Dcp2 decapping complex has a low
intrinsic activity and requires accessory factors to be fully active. Among these factors, Pat1 is considered to be a central
scaffolding protein involved in Dcp2 activation but also in inhibition of translation initiation. Here, we present the structural
and functional study of the C-terminal domain from S. cerevisiae Pat1 protein. We have identified two conserved and
functionally important regions located at both extremities of the domain. The first region is involved in binding to Lsm1-7
complex. The second patch is specific for fungal proteins and is responsible for Pat1 interaction with Edc3. These
observations support the plasticity of the protein interaction network involved in mRNA decay and show that evolution has
extended the C-terminal alpha-helical domain from fungal Pat1 proteins to generate a new binding platform for protein
partners.
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Introduction
Protein synthesis in eukaryotic cells is finely tuned both by
controlling mRNA levels and their translation. The steady-state
level of a given mRNA is governed by its rates of transcription and
degradation. Hence, the regulation of mRNA decay provides a
rapid mechanism to adapt to changing conditions. Eukaryotic
mature mRNAs are protected from fast and uncontrolled
degradation in the cytoplasm by two main cis-acting stability
determinants: a methylguanosine (m7G) cap and a poly(A) tail
present at their 59 and 39 extremities, respectively. Bulk mRNA
decay is initiated by 39 poly(A) tail shortening followed by
degradation via either the 39R59 or 59R39 mRNA decay
mechanisms [1]. In the 39R59 mRNA decay, the mRNA is
degraded by the exosome, a multiprotein complex with both exo-
and endo-nucleolytic activities embedded within a single protein
Dis3 [2,3,4,5,6]. This generates a 59 capped oligonucleotide
byproduct (less than 10 base long) that is further degraded by the
scavenger protein DcpS (Dcs1 in budding yeast) to release
m7GMP [7]. In the 59R39 pathway, the 59 cap is eliminated by
a critical and highly regulated step known as decapping, which is
followed by the rapid digestion of the mRNA body from its 59 end,
a process mediated by the exonuclease Xrn1 [8,9].
The decapping step consists in the hydrolysis of the cap
structure generating m7GDP and a 59 phosphorylated RNA
molecule. This reaction is performed by the decapping holoen-
zyme composed by the catalytic subunit Dcp2 and its co-factor
Dcp1 [10,11,12]. This complex has a low intrinsic decapping
activity and requires one or several accessory factors (such as
Lsm1-7, Pat1 or Edc1-4 proteins) to be fully efficient [13,14]. In
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particular, deletion of the LSM1-7 genes results in mRNAs
stabilization associated with accumulation of deadenylated capped
mRNAs [15,16]. These genes encode for Lsm proteins, which
associate to form the heteroheptameric Lsm1-7 complex. This
complex binds preferentially to deadenylated or oligoadenylated,
but not polyadenylated, mRNAs [17,18] and interacts with Pat1
[15,16,19]. Edc3 is another activator of decapping but EDC3
deletion does not result in the general accumulation of capped
mRNA decay intermediates. Edc3 contains an Sm/Lsm domain
and interacts with the yeast DEAD-box helicase Dhh1 (RCK/
p54/DDX6 in mammals, Me31B in fruit fly) and Pat1 (Pat1b in
mammals, HPat in fruit fly) [20,21,22,23]. Edc3 was also proposed
to associate to Dcp2 via its Lsm domain and to stimulate thereby
its enzymatic activity in vitro [24,25,26]. Finally, in fungi Edc3 was
shown to regulate the YRA1 pre-mRNA level and to interact with
the ribosomal protein Rps28 participating thereby to an autoreg-
ulatory loop controlling the decapping of mRNAs encoding this
protein [27,28,29,30]. Additional decapping activators are specific
to fungi or metazoans. In yeast, this includes the RNA-binding
proteins Edc1 and Edc2 that stimulate Dcp2 activity in vitro [31].
In contrast, metazoan EDC4 (also known as Ge-1 or Hedls
proteins) stimulates DCP2 by promoting its association with DCP1
[32,33].
The deletion of the PAT1 gene in S. cerevisiae results in a
thermosensitive growth phenotype associated with a strong
decapping inhibition in vivo [15,16,19]. These observations
revealed that Pat1 is a critical component of the decapping
machinery. As Pat1 interacts with numerous mRNA decay factors
including the Lsm1-7 complex, the 59R39 exonuclease Xrn1, the
DEAD-box helicase Dhh1, Edc3, and Dcp2 in yeast and other
organisms [15,16,19,21,22,23,26,34,35], it appears to function as a
scaffold protein allowing these proteins to form a multisubunit
assembly that mediates regulated mRNA decapping. Pat1 is
composed of several regions (domains N for N-terminal, M for
Middle and C for C-terminal) that are responsible for interaction
with various partners and that are implicated in distinct Pat1
functions. The interacting network formed by Pat1 from yeast,
drosophila and human and its partners has been dissected using
various strategies: co-immunoprecipitation of proteins expressed in
insect cells, interaction analysis using recombinant S. cerevisiae
proteins or domains, and yeast two-hybrid assays [21,26,34,36,37].
Dhh1 proteins from the three species interact with the N-terminal
domain of their Pat1 counterparts and this interaction was
proposed to modulate the interaction of Dhh1 with RNA
[20,22,34,35,36]. Other common partners of Pat1 in these three
species include the Lsm1-7 protein complex and subunits of the
decapping complex (containing Dcp1, Dcp2, and in addition
EDC4 in mammals; [38]). This is consistent with the requirement
of Pat1 and the Lsm proteins for decapping in vivo [15,16,19] and
stimulation of in vitro decapping by the S. cerevisiae Pat1 C domain
[26]. Recent structural studies have described the interaction
mode between yeast Pat1 C domain and the Lsm1-7 complex and
shown that Pat1 interacts directly with the Lsm2 and Lsm3
proteins within the Lsm1-7 complex [39,40]. Other Pat1 partners
related to mRNA decay and translational control have been
observed in one or two of these three species. This includes
subunits of the CCR4-NOT complex (human, drosophila), Scd6
(yeast), Edc3 (yeast, human) and Xrn1 (yeast, human)
[15,20,21,26,34,41]. At this stage, it is unclear whether some
interactions are species specific neither whether all these proteins
interact directly with Pat1, especially as different assays were used
(e.g., co-immunoprecipitation and two-hybrid assays versus inter-
action between purified recombinant factors). Pat1 proteins are
also nucleic acid binding proteins. Indeed, P100, the X. laevis Pat1
ortholog, binds to single-stranded but not double-stranded DNA
(RNA was not tested; [42]). In addition, yeast Pat1 and human
Pat1b domain C bind to poly(U) RNA but not poly(C) or poly(A)
[21,36].
Altogether these proteins participate to an intricate network of
protein-protein and protein-RNA interactions, which have been
proposed to promote decapping by successive steps. A model
suggests that Dhh1, Pat1 and Scd6 first repress translation and
inhibit formation of the 48S initiation complex [26]. This is
supported by the translational repression induced upon over-
expression of Pat1 and Dhh1 [43,44]. Second, remodeling of the
mRNP particles leads to recruitment of new decapping factors and
loss of eIF4E and eIF4G initiation factors, which were bound to
the cap [45]. Finally, the Pat1 and Edc3 proteins as well as the
Lsm1-7 complex activate the Dcp2 catalytic subunit [15,16,26].
However, independent experiments suggest that decapping can
also occur on translated mRNAs [46]. Pat1 and its partners co-
localize to cytoplasmic foci known as P-bodies and most of these
proteins are important for formation of these mRNP granules
[47,48,49,50]. These P-bodies contain few translation initiation
factors and are assumed to be dedicated to the storage of
translationally repressed mRNAs as well as to the decapping and
degradation of mRNAs.
In this paper, we have focused our attention on the S. cerevisiae
Pat1 C domain (ScPat1C), which is required for decapping and
involved in interaction with Lsm1-7 complex, Xrn1, Edc3, Dcp1
and Dcp2. We have determined its crystal structure and identified
two functionally important regions located at both extremities of
this domain that are important for the recruitment of different
decapping factors.
Materials and Methods
Yeast strains and shuttling plasmid
Yeast strains used in this study are listed in Table S1. Multiple
mutant strains were obtained by crossing and tetrad dissection
following standard genetic procedures. Strains BSY1133 with the
deletion of PAT1 gene and YFW168 with deletions of PAT1 and
DHH1 genes were kindly provided by Miche`le Minet.
Shuttling plasmids for complementation analyses are listed in
Table S2. Briefly, the yeast PAT1 gene was amplified from yeast
genomic DNA using oligonucleotides OBS4954 and OBS4955
(Table S3). The PCR product was cloned into XhoI/BamHI sites
of pRS414 [51] giving pBS4357. Plasmids bearing PAT1 gene with
deletions or point mutations were obtained using the Quikchange
strategy on the pBS4357 template. Oligonucleotides used in this
study are listed in Table S3.
Cell growth conditions
For complementation analyses, cells were grown to the
logarithmic phase in synthetic complete (SC) medium lacking
tryptophan complemented with 2% glucose. Cultures were diluted
to an optical density of 0.1 at 600 nm (OD600) with sterile water.
Three mL of each strain as well as three mL of three consecutive
10-fold serial dilutions were plated on SC medium lacking
tryptophan. Cell growth rate was monitored at 25uC, 30uC and
37uC after 48 or 72 hours in case of the Ddhh1/Dpat1 strain.
Two-hybrid interaction analysis
Two-hybrid interaction analyses were done using standard
procedure in two strains MAV203 (Invitrogen) and the isogenic
BSY2475 lacking Edc3 [30]. The b-galactosidase activity was
measured using Beta-Glo Assay system (Promega). Two hybrid
plasmids were constructed by standard cloning techniques after
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PCR amplification of the coding sequences. The plasmid
pBS4907, expressing PAT1 gene lacking C-terminal 68 amino
acids fused to Gal4AD, was obtained by the QuickChange strategy
using OBS5012 and OBS5013 and pBS2374 as a template.
Oligonucleotides used in this study are listed in Table S3.
Cloning, expression and purification of Pat1C proteins
The coding sequence of Pat1 C-terminal domain (hereafter
named ScPat1C encompassing residues 473 to 796) was amplified
from yeast Saccharomyces cerevisiae S288C genomic DNA with
oligonucleotides oMG18/oMG180 (see Table S3) and inserted
into pET21-a vector with a sequence coding for a His6 tag at the
39 end of the coding sequence, yielding plasmid pMG311.
The ScPat1C protein (both unlabeled or Se-Met labeled) was
expressed in E. coli Rosetta (DE3) pLysS strain (Novagen) in 2YT
medium supplemented with ampicillin at 100 mg/mL and
chloramphenicol at 25 mg/mL. At OD600=0.8, the protein
expression was induced during 20 h at 28uC by adding 50 mg/
mL IPTG. Cells were harvested by centrifugation and resus-
pended in 30 mL of buffer A (20 mM Tris-HCl pH 7.5, 200 mM
NaCl). Cell lysis was performed by sonication. The His6 tagged
protein was purified on NiNTA column (Qiagen) followed by a
heparin column (GE Healthcare) and finally on Superdex 200 16/
60 size exclusion column (GE Healthcare) in buffer A.
The DNA sequences coding for the region encompassing
residues 435 to 796 from Saccharomyces cerevisiae Pat1 mutants were
amplified from the complementation plasmids pBS4436 (mutant
Q706A/L713A), pBS4437 (mutant K475E/K476E), pBS4438
(mutant K531E/K534E/R538E), pBS4439 (mutant R497E) and
pBS4440 (mutant Q720A/R721A/D725A/R728A) using oligo-
nucleotides oMG119/oMG118 (see Table S3). They were sub-
cloned into pET21-a with a sequence coding for a N-terminal His6
tag to yield expression plasmids pMG606 (mutant Q706A/
L713A), pMG607 (mutant K475E/K476E), pMG608 (mutant
K531E/K534E/R538E), pMG609 (mutant R497E) and pMG610
(mutant Q720A/R721A/D725A/R728A).
All ScPat1 [435-796] mutants were expressed in E. coli
BL21(DE3) Codon+ (Novagen) in 1L of 2YT medium supple-
mented with ampicillin at 100 mg/mL and chloramphenicol at
25 mg/mL. At OD600=0.8, protein expression was induced at
20uC for 20 h by adding 50 mg/mL IPTG. Cells were harvested
by centrifugation and resuspended in 40 mL of buffer B (20 mM
Tris-HCl pH 8, 200 mM NaCl) supplemented with 20 mM
imidazole. Cell lysis was performed by sonication.
These mutants were purified on a NiNTA column (Qiagen),
and then on a Superdex 75 16/60 size exclusion column (GE
Healthcare) equilibrated in buffer B.
Cloning, expression and purification of the Lsm1-7
complex
A plasmid containing an operon made of the partial (Lsm4,
Lsm7) or complete (Lsm1-3, Lsm5-6) coding sequences of yeast
Lsm1-7 proteins was prepared by amplifying individually each
coding sequence containing a ribosome binding site upstream of
each start codon and unique restriction sites at both ends using
oligonucleotides OBS6352 to OBS6355 and oLsmXF/oLmsXR
(Table S3). In addition, sequences coding the His6 tag and a TEV
cleavage site were fused to the N-terminus of the Lsm1 protein.
The seven coding sequences were assembled in a stepwise manner
in the pBS3021 backbone giving plasmid pBS5031.
The Lsm1-7 complex from S. cerevisiae was expressed using
pBS5031 plasmid in E. coli BL21(DE3) Gold (Stratagene) in 1 L of
autoinducible medium at 37uC supplemented with kanamycin at
100 mg/mL. Cells were harvested by centrifugation and resus-
pended in 35 mL of buffer C (20 mM Tris-HCl pH 7.5, 500 mM
NaCl, 25 mM imidazole, 5 mM 2-mercaptoethanol). Cell lysis
was performed by sonication. The complex was purified on a
NiNTA column (Qiagen). Eluted Lsm1-7 proteins were incubated
overnight with TEV protease in dialysis buffer (20 mM Tris-HCl
pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 5 mM 2-mercaptoeth-
anol). The His-tagged TEV protease and uncleaved complex were
removed by incubation with NiNTA resin. The untagged Lsm1-7
complex was present in the flow-through and further purified by
ion exchange chromatography at pH 7.5 (HiTrap Q FF, GE
Healthcare) followed by size-exclusion chromatography on Super-
dex 200 16/60 column (GE Healthcare) in buffer D (20 mM Tris-
HCl pH 7.5, 150 mM NaCl, 5 mM 2-mercaptoethanol).
Pull-down assays
Pull-down experiments were performed by mixing 52.5 mg of
His6 tagged Pat1 [435-796] with 2 fold molar excess amounts of
untagged Lsm1-7 complex. Binding buffer (20 mM Tris-HCl
pH 7.5, 100 mM NaCl, 50 mM imidazole, 10% Glycerol) was
added to a final volume of 60 mL. The reaction mixtures were
incubated on ice for 2 hours. 10 mL was withdrawn to constitute
the input fraction. The rest was incubated with 500 mg of HisPur
Ni-NTA Magnetic Beads (Thermo Scientific) in a final volume of
200 mL at 4uC for 2 hours. Beads were washed three times with
500 mL of binding buffer. Bound proteins were eluted with
250 mM imidazole. Samples were resolved on SDS-PAGE and
visualized by Coomassie blue staining.
Crystallization and structure determination
Needle crystals were initially obtained for the ScPat1C domain
in a wide range of conditions from two commercial kits (MB Class
I and Procomplex from Qiagen) and some conditions were
optimized to obtain diffracting crystals. All the crystals were cryo-
protected by transfer into their crystallization condition with
progressively higher ethylene glycol concentration up to 30% and
then flash-cooled in liquid nitrogen. All datasets were collected on
beam-line Proxima-1 (Synchrotron SOLEIL, Saint-Aubin,
France).
A first 4 A˚ resolution dataset (crystal form I) was collected at Se-
edge from a crystal of Se-Met labeled protein obtained by mixing
1 mL of ScPat1C at 17 mg/mL in buffer A with an equal volume
of crystallization solution (4% PEG 8,000; 0.1 M Tris-HCl
pH 7.5). This dataset was processed with the MOSFLM and
SCALA programs ([52,53], Table 1). This crystal belongs to space
group P21 with two or three molecules in the asymmetric unit,
corresponding to a solvent content of 63% or 44%, respectively.
The ScPat1C structure was solved by Se-SAD using this dataset.
The SHELXD program was used to find an initial set of 12 Se
sites in the 48-5 A˚ resolution range [54]. Refinement of the Se sites
and phasing were carried out with the SOLVE program [55].
Solvent flattening and NCS averaging were performed with the
program RESOLVE [56]. The best experimental electron density
maps were obtained for a solvent content of 65%, indicating that
the asymmetric unit only contains two copies of the ScPat1C
domain. Although of poor quality due to the limited resolution,
these experimental maps allowed the building of several poly-Ala
alpha-helices.
In parallel, two additional datasets (crystal forms II and III)
could be collected from crystals of native protein (10 mg/mL in
buffer A) grown in 20% PEG 4,000; 50 mM sodium citrate; 5%
isopropanol and 15% PEG 6,000; 7.5% MPD; 0.1 M MES
pH 6.5, respectively. These datasets were processed with the XDS
package [57]. Crystal form II belongs to space group P212121 with
three ScPat1C copies in the asymmetric unit and yielded a 2.3 A˚
Structure-Function Study of Pat1 Decapping Factor
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resolution dataset. Crystal form III diffracted to 2.15 A˚ resolution
and belongs to space group P21 with 2 ScPat1C molecules in the
asymmetric unit. Statistics on data collection and refinement are
gathered within Table 1. The dataset collected from crystal form II
was then used for molecular replacement trials with the MOLREP
program [58] to locate 3 copies of the poly-Ala model built in the
4 A˚ resolution experimental map (crystal form I). Successive cycles
of building/refinement with the COOT [59] and PHENIX.RE-
FINE [60] programs yielded a final model with R and Rfree values
of 24% and 30.4%, respectively. The final model obtained from
crystal form II is incomplete due to the lack of electron density for
certain protein regions, most probably due to their intrinsic
flexibility. The final model contains residues Gly474 to Tyr787
from monomer A, Glu480 to Ile483, Phe523 to Gln694, Asp700
to Leu 795 from monomer B and Lys476 to Lys796 (as well as the
three first residues from the His-tag) from monomer C. In
addition, one ethylene glycol molecule from the cryo-protection
solution, one magnesium ion, one chloride ion and 231 water
molecules were modeled in the 2Fo-Fc electron density map.
The dataset collected from crystal form III was also used to
refine the structure of ScPat1C domain. Two copies of the Pat1C
model were positioned by molecular replacement with MOLREP
and refined using the PHENIX.REFINE program to reach final R
and Rfree values of 21% and 26.5%, respectively (Table 1). The
final model contains residues Gly474 to Ile644 and Leu654 to
Lys796 to from monomer A, Gly473 to Ser648 and Leu654 to
Lys796 from monomer B as well as 2 MES buffer molecules, 3
ethylene glycol molecules from the cryo-protection solution and
141 water molecules.
Results
Delineation of ScPat1 C domain and structure
determination
As previous studies have emphasized on the role of ScPat1 C
domain (region 422-796) in translation repression [21], in
reduction of 48S translation initiation intermediates accumulation
[26] and in localization to P-bodies [21], we decided to determine
its crystal structure to obtain information on its organization at the
atomic level. Analysis of the sequence of the ScPat1 C domain
using bioinformatics tools (i.e. secondary structure prediction,
HCA ‘‘Hydrophobic Cluster Analysis’’ tool [61]) and sequence
conservation among yeast species revealed that the region 422-472
is poorly conserved and is particularly enriched in Ser, Ala, Asn
and basic residues (Lys/Arg), which are characteristics of
unstructured regions (data not shown). On the opposite, the
region encompassing residues 473 to 796 displays significant
sequence identity within yeast species and is predicted to be well
folded. We therefore cloned the ScPat1C (473-796) domain, over-
expressed it in E. coli and purified it in milligram amounts to
homogeneity. The SeMet labeled and unlabeled proteins crystal-
lized in three different space groups (Table 1). Given the much
lower resolution of the dataset collected from crystal form I SeMet
protein crystals, this dataset was only used to obtain experimental
electron density maps by the Single wavelength Anomalous
Diffusion method (SAD) using the selenium anomalous signal
but not for structure refinement. Only structures refined to higher
resolution (crystal forms II and III) will be discussed in this
manuscript.
Three and two copies of the ScPat1C molecule are present in
the asymmetric unit of crystal forms II and III, respectively. All
these structures can be superimposed onto each other with rmsd
Table 1. Data collection and refinement statistics.
Crystal form I (Se-Met) Crystal form II Crystal form III
Data collection
Space group P21 P212121 P21
Cell dimensions
a, b, c (A˚) 112.6, 37.6, 116.8 36.3, 173.15, 175 55.2, 88.6, 68.1
a, b, c (u) 90, 99, 90 90, 90, 90 90, 96.1, 90
Resolution (A˚) 48–4.0 (4.22–4.0) 30–2.3 (2.41–2.3) 50–2.15 (2.27–2.15)
Total number of reflections 92,290 189,218 142,169
Total number of unique reflections 8,604 49,604 35,407
Rsym
a 0.113 (0.53) 0.054 (0.56) 0.081 (0.57)
I/sI 11.8 (5.3) 15.7 (2.4) 11.3 (2.1)
Completeness (%) 99.6 (100) 99.6 (98.2) 98.9 (95.8)
Redundancy 10.7 3.8 4
Refinement
Resolution (A˚) 30–2.3 50–2.15
Rwork/Rfree (%)
b 24/30.4 21/26.5
R.m.s. deviations
Bond lengths (A˚) 0.012 0.008
Bond angles (u) 1.45 1.064
PDB code 4OJJ 4OGP
aRsym=ghgi|Ihi - ,Ih.|/ghgiIhi, were Ihi is the i
th observation of the reflection h, while ,Ih. is the mean intensity of reflection h.
bRfactor=g ||Fo| - |Fc||/|Fo|. Rfree was calculated with a small fraction (5%) of randomly selected reflections.
doi:10.1371/journal.pone.0096828.t001
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values ranging from 0.3 A˚ to 1.2 A˚ over 260-310 Ca atoms. The
relatively high rmsd values observed between some molecules
result from flexibility of both N- and C-terminal extremities of this
domain (Fig.S1A). This flexibility is also supported by the
observation that residues 484-524 from one protomer as well as
residues 788-796 (corresponding to a b-sheet, see below) from
another one are ill-defined in the electron density maps and hence
absent from the final model. In parallel, two independent
structures of the ScPat1C domain bound to Lsm1-7 complex
[39] or Lsm2-Lsm3 subcomplex [40] were recently determined at
3.7 A˚ and 3.15 A˚ resolution, respectively (rmsd values ranging
from 0.9 A˚ to 1.6 A˚ with our structures of ScPat1C domain). In
these structures, the C-terminal extremity of the ScPat1C domain
exhibited higher flexibility than the remaining parts of the domain.
This is illustrated either by the absence of the C-terminal b-hairpin
and of residues 743-764 (corresponding to the end of helix a14
and the beginning of helix a15) in the structure of the Pat1-Lsm1-7
complex or by the high B-values of the residues 644-794 in the
structure of the Pat1-Lsm2-3 subcomplex compared to the other
residues from this domain. Finally, the comparison of nine
independent crystal structures has also highlighted flexibility of
the N-terminal end of human Pat1b C-terminal domain [36]. This
conserved characteristic suggests that flexible regions located at
both ends of ScPat1C domain might be of functional importance.
The crystal packing radically differs between crystal forms II
and III. In crystal form III, the two Pat1 molecules of the
asymmetric unit exhibit a very intricate head-to-tail organization
with an interacting surface area of 1,635 A˚2. As this value is in the
range expected for interfaces within homodimers [62], this
suggested that this ScPat1C domain could also exist as a
homodimer in solution. To investigate this possibility, we have
analysed the quaternary structure of ScPat1C in solution using
Figure 1. Structure of S. cerevisiae Pat1 C domain. A and B. Left panels: ribbon representation of ScPat1C crystal structure. The ARM repeats are
depicted using different colors. Middle panel: Mapping of the sequence conservation at the surface of the ScPat1C domain. Coloring is from grey (low
conservation) to cyan (highly conserved). The conservation score was calculated using the CONSURF server [67] and using an alignment made from
the sequences of 30 Pat1 fungal orthologues. Right panel: Mapping of the electrostatic potential at the surface of the ScPat1C domain. Positively
(10 kBT/e
-) and negatively (210 kBT/e
-) charged regions are colored in blue and red, respectively. The electrostatic potential was calculated using
PBEQ Solver server [68]. Orientation in B differs from A by a 180u rotation along the horizontal axis. C. Ribbon representation of the superimposition
between human Pat1C domain (green; [36]) and ScPat1C domain. The core conserved from yeast to human is colored in yellow. The fungi specific C-
terminal extension from ScPat1C is colored in red. D. Surface representation of ScPat1 domain. Same color code as panel C.
doi:10.1371/journal.pone.0096828.g001
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both size exclusion chromatography coupled online to a triple
detection array (MALLS, Fig.S1B) and small angle X-ray
Scattering (SAXS; Fig.S1C). MALLS measurements on a protein
at 2 mg/mL yielded a molecular mass of 39.3 kDa, indicating that
ScPat1C is monomeric in solution (the theoretical molecular
weight for the monomer is 38.6 kDa). Furthermore, the SAXS
experimental curves measured at various ScPat1C concentrations
(5.4 and 11.2 mg/mL, i.e. concentrations closer to those used in
the crystallization experiments) clearly correspond to the curve
calculated from the coordinates of the ScPat1C monomer but not
from those of the crystal dimer (Fig.S1C). This SAXS analysis
indicates that: first, the large contact area observed in crystal form
III is created by the crystal-packing and does not reflect a
biologically relevant oligomeric state; second, ScPat1C adopts in
solution a structure similar to that observed in the crystals.
Saccharomyces cerevisiae Pat1C is a member of the ARM
repeat superfamily
The structure of the C-terminal half of ScPat1 is formed by 15
a-helices followed by two C-terminal b strands. The a-helix
packing of the protein adopts an a-a superhelix fold reminiscent of
the ARM repeat superfamily. ScPat1C is organized as an array of
5 repeats of 3 helices stacked against each other to form a solenoid
structure (Fig.1A–B). Within each repeat, the second and third
helices are packed in an anti-parallel manner and the shorter first
helix is perpendicular to the two other helices [63]. Within the
superhelix, the second and third helices from a repeat are stacked
against the second and third helices from the neighboring repeats,
respectively. The first helices from each repeat are all exposed to
the same face of the solenoid. In the ScPat1C domain, the first
helix from repeat 1 is absent and the length of the ARM repeats
ranges in length from around 40 to 70 amino acids. The fifth and
final motif is capped at its C-terminal end by helix a15 followed by
a two-stranded anti-parallel b-hairpin, which folds back onto
helices a14 and a15. These two latter helices are long (25 to 30
residues long) and protrude from the core of the protein.
The ScPat1C domain adopts the same fold as the corresponding
domain from human Pat1b (rmsd value of 3.4–3.8 A˚ over 200 Ca
atoms and 20% sequence identity, Fig.1C, [36]). The highest
structural similarity is found in the region encompassing residues
476 to 680 from yeast (520–732 from human Pat1b). The C-
terminal part of this domain (680–796 in yeast and 733–765 in
human) is much more divergent and in particular, S. cerevisiae
protein exhibits a significantly longer C-terminal extension with
two long a-helices (a14, a15) and a two stranded b-hairpin
(Fig.1A-B & D). This C-terminal extension, which also encom-
passes helix a12, is specific for fungi and varies in length among
yeast species (Fig.2).
Mapping of the sequence conservation at the surface of the
ScPat1C reveals the presence of two highly conserved regions
(Fig.1A-B). The first region is conserved both in fungal and in
metazoan proteins and has very recently been shown to be directly
involved in the interaction with the Lsm1-7 complex [39,40]. It is
mainly formed by residues located within helices a1 (Lys475,
Lys476, Glu483, Glu493 and Arg497) and a4 (Lys531, Lys534
and Arg538) and displays a positively charged electrostatic
potential (Fig.1A; Fig.2). The other conserved region is located
at the opposite side of the domain and corresponds to the fungi
specific region (Fig.1B; Fig.2). This region is formed by the C-
terminal end of ScPat1C (helices a13, a14, a15 and strands b1
and b2) and is electrostatically neutral.
The conserved positively charged N-terminal region from
ScPat1C involved in the interaction with Lsm1-7
complex, is important for yeast growth at 37uC
To test for the importance of the conserved region located at the
N-terminal extremity of ScPat1 domain, we have used comple-
mentation of Pat1 mutants (Fig.3). Since Pat1 is known to
collaborate with other factors to induce mRNA decay and repress
translation, we first constructed strains carrying deletion of PAT1
alone or in combination with DHH1, or with EDC3 and SCD6
deletions. Consistent with previous observation, deletion of PAT1
resulted in slow growth phenotype at 25uC or 30uC and
thermosensitivity at 37uC (Fig.3B; [15,16,19]). Exacerbated
phenotypes, supporting partly redundant functions, were observed
in both the edc3D/scd6D/pat1D and dhh1D/pat1D strains. This is
consistent with previous observations and with the participation of
these factors in translation repression and/or mRNA decay [64].
Full-length Pat1 protein fully complements for the deletion of the
PAT1 gene in all these strains while a Pat1 fragment lacking the
crystallized ScPat1C domain (Pat1 [1–472] or Pat1DC) does not,
indicating that this C-terminal domain is functionally important
(Fig.3B). Based on this observation, we next mutated residues
located within the conserved N-terminal region from ScPat1C by
substituting lysine and arginine residues from helices a1 and a4 by
glutamic acid (Fig.3A). This yielded three charge-inversion
mutants (K475E/K476E, R497E and K531E/K534E/R538E)
whose ability to complement for PAT1 deletion was tested in the
three different genetic backgrounds. While the R497E and
K475E/K476E mutants behave mostly as the wild-type ScPat1
protein, the K531E/K534E/R538E mutant exhibits a slightly
reduced complementation in the pat1D strain (detected as smaller
colonies), and does not complement for PAT1 deletion in dhh1D
and edc3D/scd6D strains (Fig.3B). Furthermore, as no complemen-
tation defects are detectable at 25uC or 30uC for these three
mutants, we conclude that these mutants are functional and well
folded. This was confirmed by normal accumulation of these
different point mutant proteins in yeast cells (Fig.S2). Altogether,
these complementation analyses indicate that the positively
charged conserved region and in particular K531, K534 and
R538 residues, found at the N-terminal region of ScPat1C play an
important functional role, that is more easily detected in the
absence of the Dhh1 helicase or of the Edc3 and Scd6 proteins.
These functionally important conserved residues are located
within the ScPat1C region interacting with the Lsm1-7 complex
[39,40]. As the charge inversion mutants that we have tested in
our phenotypic analyses were not generated previously (only
substitutions of some of these residues by Ala were performed
[39,40]), we have investigated whether the complementation
defects observed for the ScPat1C mutants could result from the
inability of our mutants to interact with Lsm1-7 complex. We have
purified the Lsm1-7 complex as well as various ScPat1C mutants
following over-expression in E. coli and performed pull-down
assays. As shown in Fig.3C, the untagged Lsm1-7 complex was
specifically retained on NiNTA beads when incubated with the
wild-type His6 tagged ScPat1 fragment encompassing residues
435-796 (i.e. slightly longer than ScPat1C). Similarly, the R497E
mutant as well as two other mutants targeting residues located
within the opposite C-terminal extension present in Pat1 fungal
proteins (Q706A/L713A and Q720A/R721A/D725A/R728A)
interact to the same extent as the wild-type ScPat1 domain.
Interestingly, the K475E/K476E and K531E/K534E/R538E
ScPat1 mutants failed to interact with the Lsm1-7 complex,
confirming that the conserved positively charged residues (K475,
K476, K531, K534 and R538) located within this N-terminal
region from ScPat1C are directly involved in the interaction with
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the Lsm1-7 complex. Furthermore, in the case of the K531E/
K534E/R538E ScPat1 mutant, the disruption of Lsm1-7-Pat1C
interaction suggests that this interaction is crucial for yeast growth
at 37uC in the absence of Scd6 and Edc3 proteins (Fig.3B).
Although we did not detect interaction between K475E/K476E
ScPat1C mutant and the Lsm1-7 complex in vitro, this mutant
complements for the deletion of PAT1 gene in the different
background tested. This could indicate that this later mutant
retains some residual binding activity towards the Lsm1-7 complex
in vivo and this would be sufficient to support yeast growth at 37uC
(see discussion).
The yeast specific C-terminal extension from ScPat1C is
involved in Edc3 binding
We next investigated whether the second conserved region, i.e.
the fungi specific C-terminal extension is important for Pat1
biological function (Fig.4). We used the same yeast strains to assess
the ability of ScPat1 lacking residues 730 to 796 from this C-
terminal extension (ScPat1DC68) to complement for the deletion
of PAT1 gene (Fig.4B). This truncated protein was unable to fully
restore growth at 37uC upon expression in all mutant strains with
the strongest phenotypes again observed in the pat1D/scd6D/edc3D
and pat1D/dhh1D strains (Fig.4B). A pat1D strain carrying a
deletion of the ScPat1 C-terminal extension grows only slightly
better than a strain with Pat1DC and both deletions have similar
effects in the pat1D/dhh1D and pat1D/scd6D/edc3D backgrounds.
Hence, our data support that this C-terminal extension plays a
functional role, whose importance is better detected in the more
sensitive double mutant strains.
We next investigated the importance of well-conserved residues
within this region by substituting them by Ala to yield three
different mutants: Q706A/L713A, Q720A/R721A/D725A/
R728A and E794A (Fig.4A). All these mutants were expressed at
similar levels as the wild-type protein in yeast (Fig.S2) and fully
complemented for PAT1 deletion in the three backgrounds tested
indicating that they are not affected in their function. Surprisingly,
Figure 2. Sequence alignment of Pat1 orthologues. Alignment was performed using ClustalW [69]. Strictly conserved residues are in white on a
black background. Partially conserved amino acids are boxed. Secondary structure elements assigned from the ScPat1C structure are indicated above
the alignment. Black stars below the sequences indicate residues mutated in this study. This figure was generated using the ESPript server [70].
doi:10.1371/journal.pone.0096828.g002
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the pat1D/scd6D/edc3D and pat1D/dhh1D strains expressing the
Q706A/L713A and Q720A/R721A/D725A/R728A mutants
grew faster at 37uC than the same strains expressing full-length
wild-type Pat1 (Fig.4B).
To go deeper into the role of this Pat1 fungi specific C-terminal
extension, we tested the ability of full-length ScPat1 and
ScPat1DC68 to interact with Rps28, Edc3 and Scd6 in a two-
hybrid assay (Fig.4C). In a wild type strain background, we could
detect the Pat1-Edc3 interaction that was previously reported [21]
as well as positive signals for Pat1-Rps28 and Pat1-Scd6. The
association with Rps28 and Scd6 were not previously observed
using the two-hybrid assay but independent evidences support our
observations. Indeed, an interaction between Pat1 and Scd6 was
observed using purified factors [26]. Similarly, Rps28 is known to
interact with Edc3 which itself binds Pat1 [30]. Interestingly,
neither Edc3 nor Rps28 interact with the ScPat1DC68 protein
while Scd6 interacts as efficiently as with the full-length Pat1
protein (Fig.4C). The latter observation indicates that
ScPat1DC68 is well folded and functional. In the Dedc3 host
strain, Rps28 was unable to interact with wild type ScPat1
revealing thereby that Edc3 is necessary to bridge the two factors.
We observed that the Pat1-Edc3 interaction signal was much
stronger (more than 60 fold) in the Dedc3 strain compared to wild
type. This indicates that endogenous Edc3 competes with Edc3
fused to the DNA binding domain for interacting with Pat1. Even
with the very high signal observed in this context, deletion of the
C-terminal region of Pat1 totally abolished the interaction with
Edc3 (Fig.4C). The Scd6-Pat1 interaction signal was only slightly
enhanced in the Dedc3 strain (3-fold) and remained strongly
positive with the ScPat1DC68 in this context. Thus, Scd6 interacts
with Pat1 through an interface that remains to be identified but
that differs at least in part from the one mediating Edc3 binding,
as it does not require the fungal C-terminal extension of Pat1.
Consistently, Edc3 competed only weakly with the Scd6-Pat1
interaction.
In summary, these data demonstrate that the C-terminal
extension specific to fungal Pat1 proteins plays an important
functional role, probably through its ability to mediate interaction
with protein partners including Edc3.
Discussion
The Pat1 protein is involved in different aspects of mRNA
decapping activation. Indeed, Pat1 represses translation initiation
with its Dhh1 and Scd6 partners [22,26,43] but also activates the
Dcp1-Dcp2 enzyme together with Edc3 and, in yeast, Edc1 and
Edc2 [26,31]. Pat1 also interacts with the Lsm1-7 complex, which
binds to the 39 end of oligoadenylated mRNAs, thereby
connecting 39 to 59 and 59 to 39 mRNA decay pathways
[15,16,20,34,65]. Hence, Pat1 is considered as a central platform
protein for decapping. Our present study further reinforces this
Figure 3. The conserved residues at the N-terminal residues are
involved in interaction with Lsm1-7. A. ScPat1C structure with the
residues mutated in this study shown as ball and sticks. Color scheme
identical to Fig.1A. B. Growth analysis of PAT1 mutants. Serial dilutions
of the different strains transformed with vector, a plasmid encoding
wild type ScPat1, or the indicated mutant thereof, were deposited on
plates and incubated at the indicated temperatures. C. Pull-down
experiment of untagged Lsm1-7 complex with His6 ScPat1C wild type
or mutants. Input (top) and eluted (bottom) samples were analyzed by
22% SDS-PAGE and Coomassie Blue staining. The asterisk denotes a
contaminant protein that co-purifies with the Lsm1-7 complex but
which is not retained on the HisPurTM Ni-NTA Magnetic Beads used for
these pull-down experiments. Molecular weights (kDa) of the markers
are indicated on the left of the gels.
doi:10.1371/journal.pone.0096828.g003
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idea. Indeed, the crystal structure of the S. cerevisiae Pat1C shows
that this domain structurally belongs to the ARM repeat
superfamily, which mostly encompasses proteins involved in
protein-protein interaction. This is consistent with already
published data that have identified many protein partners for this
domain (Lsm1-7, Xrn1, Dcp1, Dcp2, Edc3 in yeast, human and/
or drosophila as well as EDC4 in human; [15,20,26,34,36]).
Furthermore, sequence conservation mapping at the surface of
ScPat1C domain reveals the presence of conserved residues
clustered at both extremities of this domain and involved in
protein recruitment by Pat1.
The first conserved region is located at the N-terminal part of
the ScPat1C domain and the corresponding region from HPat was
previously shown to be involved in the recruitment of the LSM1-7
complex, DCP2 and EDC4 proteins by co-immunoprecipitation
experiments performed in D. melanogaster cells [36]. Recently, two
independent crystal structures of ScPat1C-Lsm1-7 and ScPat1C-
Lsm2-3 complexes clearly showed that this region (and in
particular residues K475, K476, K531, K534 and R538) is
involved in the interaction with Lsm3 within the Lsm1-7 complex
[39,40]. Furthermore, the mutation of some of these residues
resulted in mRNA stabilization by altering mRNA decapping and
39R59 decay in vivo [40]. We have observed that this N-terminal
conserved region from Pat1C is indeed of functional importance as
illustrated by the thermosensitive phenotype observed for pat1D/
scd6D/edc3D and pat1D/dhh1D yeast strains expressing the Pat1
K531E/K534E/R538E mutant (Fig.3B). We further confirmed
that this ScPat1 mutant, which was not generated in the other
studies, fails to interact directly with the Lsm1-7 complex using in
vitro pull-down assays (Fig.3C). Contrary to the K531E/K534E/
R538E mutant, the K475E/K476E mutant does not interact with
Lsm1-7 complex in vitro but fully complements for the deletion of
ScPat1 in vivo (Fig.3B-C). This most probably results from the
location of the K475 and K476 residues at the periphery of the
ScPat1C-Lsm1-7 interface while the K531, K534 and R538
residues are located at the center of this interaction [39,40].
Indeed, one can speculate that the interaction between the Lsm1-7
complex and ScPat1C K475E/K476E mutant domain is too weak
to resist the conditions of the in vitro pull-down assay performed
with purified truncated Pat1 proteins while, in vivo, a residual
interaction probably strengthened by the bridging activity of other
decapping factors is likely to take place with this full-length ScPat1
mutant and to be sufficient for function. Altogether, these different
studies rationalize the functional importance of these conserved
Pat1 residues and indicate that the physical interaction between
Pat1 and the Lsm1-7 complex is crucial for yeast cell growth at
37uC in the absence of Dhh1 or Edc3 and Scd6 proteins. This
further strongly suggests that the growth defects that we observe
for the K531E/K534E/R538E mutant is most likely the result of
the inability of this mutant to interact with Lsm1-7 complex and
then to activate mRNA decapping and 39R59 decay in vivo.
Opposite to the ScPat1C region involved in the interaction with
Lsm1-7 complex, there is a fungi-specific C-terminal extension
(encompassing residues 730–796 from ScPat1), which is important
for growth at 25uC, 30uC and 37uC in the absence of the DHH1
gene or of both EDC3 and SCD6 genes (Fig.4B). Expression of the
ScPat1DC68 protein in a Dpat1 background also results in a slight
Figure 4. The yeast specific residues located at the C-terminus
of ScPat1C are functionally important. A. ScPat1C structure with
the residues mutated in this study shown as ball and sticks. Color
scheme identical to Fig.1A. The region absent in the ScPat1DC68
construct is colored in grey. B. Growth analysis of PAT1 mutants. Serial
dilutions of the different strains transformed with vector, a plasmid
encoding wild type ScPat1, or the indicated mutant thereof, were
deposited on plates and incubated at the indicated temperatures. C.
Monitoring ScPat1 interaction with Edc3, Rps28 or Scd6 using the two-
hybrid assay. The wild-type or edc3D strain was transformed with the
indicated pairs of vectors and interaction between the factors encoded
by these two plasmids was scored by assaying b-galactosidase activity.
doi:10.1371/journal.pone.0096828.g004
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growth defect at 37uC. Furthermore, we have observed using yeast
two-hybrid that ScPat1DC68 no longer interacts with Edc3 and
Rps28 (Fig.4C). The interaction with Rps28 requires Edc3, which
itself interacts with Rps28 through a conserved linear motif [30].
However, the ScPat1DC68 protein still binds to Scd6, indicating
that this truncated version of the protein is still present and folded
in yeast. A previous report indicated that residues 697–763 from
ScPat1 are required for recruitment of Lsm1-GFP to P-bodies and
for the interaction of Pat1 with Edc3 but not Lsm1 [21]. As our
structural information indicate that this internal deletion affects
both the conserved and non-conserved regions of ScPat1, it was
not possible to conclude about the role of the yeast specific region
(residues 729 to 796) from these data. Our results indicate that it is
required for Edc3 binding but it remains to be determined
whether the Pat1-Edc3 interaction is direct or bridged by other
decapping factors. Indeed, ScPat1C domain was shown to interact
physically with Dcp2, which in turn should interact with Edc3 Lsm
domain through several short helical leucine-rich motifs (HLM) as
shown in S. pombe [24,26]. Furthermore, no interaction between
Edc3 and Pat1 proteins was detected by co-immunoprecipitation
in D. melanogaster cells while the association described for human
proteins was proposed to be indirect [20,34]. Hence, the
involvement of the ScPat1 C-terminal and fungal specific
extension in the interaction with Edc3 is of particular interest.
Other species-specific variations in the interaction network of
decapping factors have been observed. For example, while the
interaction between Dcp1 and Dcp2 is direct in yeast, it is
strengthened by EDC4/Hedls in human [32,33]. Similarly, the
Edc3 and Scd6 Lsm domains interact with Dcp2 through short
helical leucine-rich motifs (HLM) in S. pombe while in metazoan,
the HLM motif involved in EDC3 binding is present in DCP1
[24]. It has been proposed that phylogenetic variations in this
protein interaction network arise through the appearance of Short
Linear Interaction Motifs (SLiMs), which are intrinsically disor-
dered when unbound [66]. While the appearance and evolution of
such motifs are easy to envisage, our observation that yeast Pat1
proteins contain a C-terminal extension that is structured and
required for Edc3 binding, indicates that evolution can also
promote the formation of more complex and structured protein
appendages that facilitate protein association.
In conclusion, the crystal structure of the ScPat1 C-terminal
domain has revealed two functionally important regions localized
at opposite extremities of the domain. One region is enriched in
positively charged residues and is important for yeast growth at
37uC. It is involved in direct binding to the Lsm1-7 complex that is
required for decapping activation. The second region is required
for the interaction of ScPat1 with Edc3 and its precise role remains
to be elucidated.
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Figure S1 A. Superimposition of the five ScPat1C structures
(each ScPat1C structure is shown with a different color). The rmsd
values range from from 0.3 A˚ to 1.2 A˚ over 260-310 Ca atoms. B.
Size-exclusion chromatogram of ScPat1C is shown. For clarity,
only the refractive index (RI, red, left y axis) for the eluted sample
and the molecular mass calculated from light scattering (right y
axis, black, logarithmic scale) are shown. C. Comparison between
the experimental curve (open circles) obtained for ScPat1C and
the curve (red line) calculated using the program CRYSOL from
the crystal structure of the Pat1 monomer to which the missing C-
ter His6 tag was added [7]. The excellent agreement (x=1.56)
between these curves proves unambiguously that ScPat1C is a
monomer in solution at low concentration below a few mg/mL
and that the structure of the protein in solution is comparable to
the crystal structure. For comparison the curve calculated from the
coordinates of the crystal dimer (dashed gray line) is also shown.
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Figure S2 Western blot analysis of protein levels for full-length
and point mutant derivatives of ScPat1. Lsm1 was used as a
loading control.
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